Ephrat Levy‐Lahad

18.2k citations

163 papers · 10.0k indexed · 4 hit papers · h-index 44

Molecular Biology top 1%
Genetics top 0.2%
Physiology top 0.5%
Immunology top 2%
Pediatrics, Perinatology and Child Health top 0.5%

Co-authors: Paul Renbaum Thomas D. Bird Amnon Lahad Ellen M. Wijsman Ellen Nemens Mary‐Claire King Eitan Friedman Gerard D. Schellenberg
Topics: BRCA gene mutations in cancer (38 papers)Prenatal Screening and Diagnostics (27 papers)Genomic variations and chromosomal abnormalities (16 papers)
Cited by: Physiology Genetics Biological Psychiatry
Journals: Science New England Journal of Medicine Proceedings of the National Academy of Sciences
Partner nations: Israel United States United Kingdom

In The Last Decade

Ephrat Levy‐Lahad

157 papers receiving 9.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Candidate Gene for the Chromosome 1 Familial Alzheimer's Disease Locus

1995 2.0k citations Ephrat Levy‐Lahad et al. profile →
X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy

2001 1.4k citations Robert S. Wildin, Ephrat Levy‐Lahad et al. profile →
A Familial Alzheimer's Disease Locus on Chromosome 1

1995 594 citations Ephrat Levy‐Lahad et al. profile →
Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline

2022 98 citations Cristiana Sessa, Judith Balmañà et al. Annals of Oncology profile →

Peers

Countries citing papers authored by Ephrat Levy‐Lahad

Since Specialization

Citations

This map shows the geographic impact of Ephrat Levy‐Lahad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ephrat Levy‐Lahad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ephrat Levy‐Lahad more than expected).

Fields of papers citing papers by Ephrat Levy‐Lahad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ephrat Levy‐Lahad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ephrat Levy‐Lahad. The network helps show where Ephrat Levy‐Lahad may publish in the future.

Co-authorship network of co-authors of Ephrat Levy‐Lahad

This figure shows the co-authorship network connecting the top 25 collaborators of Ephrat Levy‐Lahad. A scholar is included among the top collaborators of Ephrat Levy‐Lahad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ephrat Levy‐Lahad. Ephrat Levy‐Lahad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TP53 missense allele predisposing to high risk of breast cancer but not pediatric cancers 2024 ·JNCI Journal of the National Cancer Institute ·(unknown),Sari Lieberman,(unknown),(unknown),Ming K. Lee,Süleyman Gülsüner,(unknown),Rachel Beeri,Amal Abu Rayyan,Jessica B. Mandell,Hila Fridman,(unknown),(unknown),(unknown),Amnon Lahad,Mary‐Claire King,Ephrat Levy‐Lahad,Moien Kanaan	0
2	Real World Cost-Effectiveness Analysis of Population Screening for BRCA Variants among Ashkenazi Jews Compared with Family History-Based Strategies 2022 ·Cancers ·Rachel Michaelson‐Cohen,Matan J. Cohen,(unknown),Dan Greenberg,Amir Shmueli,Sari Lieberman,(unknown),Ephrat Levy‐Lahad,Amnon Lahad	4
3	Machine-learning of complex evolutionary signals improves classification of SNVs 2022 ·NAR Genomics and Bioinformatics ·(unknown),Doron Stupp,(unknown),(unknown),(unknown),Ephrat Levy‐Lahad,Paz Polak,Tal Pupko,Yuval Tabach	4
4	Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guidelinebreakdown → 2022 ·Annals of Oncology ·Cristiana Sessa,Judith Balmañà,Sharon L. Bober,Maria João Cardoso,(unknown),Giuseppe Curigliano,Susan M. Domchek,D. Gareth Evans,D. Fischerová,Nadia Harbeck,Christiane Kühl,Birthe Lemley,Ephrat Levy‐Lahad,Matteo Lambertini,Jonathan A. Ledermann,Sibylle Loibl,Kelly‐Anne Phillips,Shani Paluch–Shimon	98
5	The landscape of autosomal-recessive pathogenic variants in European populations reveals phenotype-specific effects 2021 ·The American Journal of Human Genetics ·Hila Fridman,Helger G. Yntema,Reedik Mägi,Reidar Andreson,Andres Metspalu,Massimo Mezzavilla,Chris Tyler‐Smith,Yali Xue,Shai Carmi,Ephrat Levy‐Lahad,Christian Gilissen,Han G. Brunner	34
6	Helicase-inactivating BRIP1 mutation yields Fanconi anemia with microcephaly and other congenital abnormalities 2020 ·Molecular Case Studies ·(unknown),Sarah B. Pierce,Christina Canavati,Amal Abu Rayyan,(unknown),(unknown),(unknown),Barbara M. Norquist,(unknown),(unknown),Ephrat Levy‐Lahad,Mary‐Claire King,Moien Kanaan	5
7	Preconception carrier screening yield: effect of variants of unknown significance in partners of carriers with clinically significant variants 2019 ·Genetics in Medicine ·Hila Fridman,Doron M. Behar,Shai Carmi,Ephrat Levy‐Lahad	23
8	Population screening for BRCA1/BRCA2 mutations: lessons from qualitative analysis of the screening experience 2016 ·Genetics in Medicine ·Sari Lieberman,Amnon Lahad,(unknown),(unknown),Ephrat Levy‐Lahad,Aviad E. Raz	25
9	Combined mineralocorticoid and glucocorticoid deficiency is caused by a novel founder nicotinamide nucleotide transhydrogenase mutation that alters mitochondrial morphology and increases oxidative stress 2015 ·Journal of Medical Genetics ·Ariella Weinberg‐Shukron,Abdulsalam Abu‐Libdeh,(unknown),Liran Carmel,Aviram Kogot‐Levin,(unknown),Moien Kanaan,Sharon Zeligson,Paul Renbaum,Ephrat Levy‐Lahad,David Zangen	28
10	Dr. Segel and colleagues reply 2014 ·Lirias (KU Leuven) ·Reeval Segel,Mary‐Claire King,Ephrat Levy‐Lahad	50
11	BRCA genetic testing of individuals from families with low prevalence of cancer: experiences of carriers and implications for population screening 2012 ·Genetics in Medicine ·Shiri Shkedi‐Rafid,(unknown),Julia Grinshpun‐Cohen,Ephrat Levy‐Lahad	17
12	Garrod's fourth inborn error of metabolism solved by the identification of mutations causing pentosuria 2011 ·Proceedings of the National Academy of Sciences ·Sarah B. Pierce,Cailyn H. Spurrell,Jessica B. Mandell,Ming K. Lee,Sharon Zeligson,Michael S. Bereman,Sunday M. Stray,Siv Fokstuen,Michael J. MacCoss,Ephrat Levy‐Lahad,Mary‐Claire King,Arno G. Motulsky	11
13	Female Sex Bias in Human Embryonic Stem Cell Lines 2011 ·Stem Cells and Development ·Dalit Ben‐Yosef,Ami Amit,Mira Malcov,Tsvia Frumkin,Ahmi Ben‐Yehudah,Ido Eldar,(unknown),Foad Azem,Gheona Altarescu,Paul Renbaum,Rachel Beeri,(unknown),Talia Eldar‐Geva,Silvina Epsztejn‐Litman,Ephrat Levy‐Lahad,Rachel Eiges	21
14	Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin 2009 ·Oncogene ·Ingo Wolf,Yael Laitman,Tamar Rubinek,Lilach Abramovitz,Ilya Novikov,Rachel Beeri,Makoto Kuro‐o,H. Phillip Koeffler,Raphael Catane,L. S. Freedman,Ephrat Levy‐Lahad,Beth Y. Karlan,Eitan Friedman,Bella Kaufman	40
15	Real-time reverse linkage using polar body analysis for preimplantation genetic diagnosis in female carriers of de novo mutations 2009 ·Human Reproduction ·Gheona Altarescu,Talia Eldar‐Geva,(unknown),B. Brooks,(unknown),Ehud J. Margalioth,Ephrat Levy‐Lahad,Paul Renbaum	20
16	(TA)n UGT 1A1 Promoter Polymorphism: A Crucial Factor in the Pathophysiology of Jaundice in G-6-PD Deficient Neonates 2007 ·Pediatric Research ·Michael Kaplan,Paul Renbaum,Hendrik J. Vreman,Ronald J. Wong,Ephrat Levy‐Lahad,Cathy Hammerman,David K. Stevenson	27
17	Hemolysis and bilirubin conjugation in association with UDP-glucuronosyltransferase 1A1 promoter polymorphism 2002 ·Hepatology ·Michael Kaplan,Cathy Hammerman,Firmino F. Rubaltelli,Maria Teresa Vilei,Ephrat Levy‐Lahad,Paul Renbaum,Hendrik J. Vreman,David K. Stevenson,Maurizio Muraca	40
18	Neonatal diabetes mellitus, enteropathy, thrombocytopenia, and endocrinopathy: Further evidence for an X-linked lethal syndrome 2001 ·The Journal of Pediatrics ·Ephrat Levy‐Lahad,Robert S. Wildin	56
19	The Founder Mutations in the BRCA1 , BRCA2 , and ATM Genes in Moroccan Jewish Women with Breast Cancer 2000 ·Genetic Testing ·Yitshak Kreiss,(unknown),Ruth Gershoni Baruch,Ephrat Levy‐Lahad,Elon Pras,Eitan Friedman	10
20	Adult-type Gaucher disease in children: genetics, clinical features and enzyme replacement therapy. 1993 ·PubMed ·Shoshana Zevin,Aya Abrahamov,Irith Hadas‐Halpern,(unknown),Ephrat Levy‐Lahad,Mia Horowitz,Ari Zimran	39

About Ephrat Levy‐Lahad

Ephrat Levy‐Lahad is a scholar working on Genetics, Reproductive Medicine and Pediatrics, Perinatology and Child Health, having authored 163 papers that have together received 10.0k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (38 papers), Prenatal Screening and Diagnostics (27 papers) and Genomic variations and chromosomal abnormalities (16 papers). The work is most often cited by research in Physiology (3.1k citations), Genetics (3.2k citations) and Biological Psychiatry (256 citations). Ephrat Levy‐Lahad has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Paul Renbaum, Thomas D. Bird, Amnon Lahad, Ellen M. Wijsman, Ellen Nemens, Mary‐Claire King, Eitan Friedman, Gerard D. Schellenberg, Parvoneh Poorkaj and Robert S. Wildin. Their work appears in journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact